/Companies

Vektor Medical

Carlsbad, US · Founded 2017 · Delaware corporation · 3 known investors

Find your way into Vektor Medical

Each arrow is one introduction. Sign up to fill in the first one.

168 people can intro you to Chris

Ask Joshua Eckelberry to introduce you to Chris Villongco

You →Joshua · together at Vektor Medical, Inc. →Chris

116 people can intro you to Rob

Ask Jamie Chen to introduce you to Rob Krummen

You →Jamie · together at Vektor Medical, Inc. →Rob

Sign up to find every way you can get introduced to Vektor Medical

  • Your email: who you already know at Vektor Medical, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vektor Medical team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.

Founders & leadership

Vektor Medical was founded in 2017 by Chris Villongco.

CV
Chris VillongcoHead of Technology / CTOChris Villongco holds a Ph.D. in Bioengineering with specialization in computational modeling of cardiac physiology and has a background in mechanical engineering. As Head of Technology at Vektor Medical, he oversees development of patient-specific computational models to support diagnosis and treatment of cardiac arrhythmias.
RKRob Krummen
Rob KrummenCEO (formerly President & COO)Rob Krummen joined Vektor Medical in 2018 as Chief Operating Officer and General Counsel, advancing to President and COO in 2021 before becoming CEO in 2022. He has led the company through funding rounds, regulatory approvals, and product launches in cardiac electrophysiology.
KPKelly Perez
Kelly PerezHead of Finance
AM
Alexander Michael MonkoNamed on SEC filing

Investors · 3

Reported raises · per SEC filings

Form D private placements

$32.9M disclosed across 5 rounds · 2018–2024

▶$28.9MraisedFeb 2024 · 98 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joe BraidwoodExecutive Officer
  • C. David AdairDirector
  • Lana CaronExecutive Officer
  • Robert J. KrummenExecutive Officer, Director
  • Shannon St. ClairExecutive Officer
  • Chris VillongcoExecutive Officer
  • Luc MarengereDirector
  • Douglas S. KomenExecutive Officer
  • Alexander M. MonkoExecutive Officer, Director
Offering amount
$37.5M
Amount sold
$28.9M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.6MraisedNov 2019 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kalle MarsalDirector
  • Robert J. KrummenDirector
  • Alexander Michael MonkoExecutive Officer, Director
Offering amount
$5M
Amount sold
$3.6M
Minimum investment
$25K
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.3KraisedJul 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris VillongcoExecutive Officer
  • Robert J. KrummenExecutive Officer, Director
  • Alexander Michael MonkoExecutive Officer, Director
Offering amount
$11.3K
Amount sold
$11.3K
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.2KraisedMay 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert J. KrummenExecutive Officer, Director
  • Chris VillongcoExecutive Officer
  • Alexander Michael MonkoExecutive Officer, Director
Offering amount
$12.2K
Amount sold
$12.2K
First sale
Apr 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$370KraisedFeb 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris VillongcoExecutive Officer
  • Alexander Michael MonkoExecutive Officer, Director
  • Robert J. KrummenDirector
Offering amount
$2.5M
Amount sold
$370K
Proceeds to insiders
$270K
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Vektor Medical.

Frequently asked questions

What does Vektor Medical do?
Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.
Who founded Vektor Medical?
Vektor Medical was founded by Chris Villongco in 2017.
Who are Vektor Medical's investors?
Vektor Medical's investors include Solas BioVentures, TVM Capital, TVM Capital Life Science.
How much funding has Vektor Medical raised?
Vektor Medical has disclosed $32.9M raised across 5 rounds.
Where is Vektor Medical headquartered?
Vektor Medical is headquartered in Carlsbad, US.